- ホーム
- > 洋書
- > 英文書
- > Business / Economics
Full Description
Systemic Drug Delivery Strategies: Delivery Strategies and Engineering Technologies in Cancer Immunotherapy, Volume 2 examines the challenges of delivering immuno-oncology therapies, focusing specifically on the multiple technologies of affective drug delivery strategies. Immuno-oncology (IO) is a growing field of medicine at the interface of immunology and cancer biology leading to development of novel therapeutic approaches, such as chimeric antigen receptor T-cell (CAR-T) and immune checkpoint blockade antibodies, that are clinically approved approaches for cancer therapy. Although currently approved IO approaches have shown tremendous promise for select types of cancers, broad application of IO strategies could even further improve the clinical success, especially for diseases such as pancreatic cancer, brain tumors where the success of IO so far has been limited. This volume of Delivery Strategies and Engineering Technologies in Cancer Immunotherapy discusses methods of targeting tumors, CRISPR technology, and vaccine delivery among many other delivery strategies.
Systemic Drug Delivery Strategies: Delivery Strategies and Engineering Technologies in Cancer Immunotherapy, Volume 2 creates a comprehensive treaty that engages the scientific and medical community who are involved in the challenges of immunology, cancer biology, and therapeutics with possible solutions from the nanotechnology and drug delivery side.
Contents
1. Delivery strategies for immune checkpoint blockade inhibitors
2. Delivery strategies for ex vivo and in vivo T-cell reprogramming
3. Delivery strategies for ex vivo and in vivo NK cell reprogramming
4. Delivery strategies for tumor-associated macrophage reprogramming
5. Reprogramming lymphocytes for tumor immunotherapy
6. Targeting tumor-associated neutrophils in immunotherapy
7. Targeting tumor-associated fibroblast in immunotherapy
8. Oncolytic viral particle delivery
9. Extracellular vesicles (exosomes) in tumor immunotherapy
10. Nucleic acid-based delivery and reprogramming for tumor immuno-oncology
11. CRISPR-based gene editing in cancer immunotherapy
12. Delivery strategies for glioma immunotherapy
13. Delivery strategies for STING agonists
14. Delivery strategies for cancer vaccine and immunoadjuvant
15. Targeted delivery and reprogramming myeloid-derived suppressor cells (MDSC) in cancer
16. Delivery of radio-immunotherapy for solid tumors
17. Delivery of photo-immunotherapy for cancer
18. Local immunotherapy of cancer and metastasis
19. Delivery strategies to overcome tumor immunotherapy resistance
